Navigation Links
NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
Date:4/8/2013

ior manager from big pharma, who has taken blockbuster drugs through development and into commercialization;
  • expansion of the Company's Board with experts in the biotech/pharma sector and in manufacturing; and
  • issuance of a dozen new patents in the Company's worldwide patent portfolio.
  • The Company's cash expenditures of $22.8 million for all of these operations in 2012 were substantially below the level of expenditures usually seen with companies that are in large Phase III clinical trials, and/or that have multiple product development programs under way, especially with operations on two continents.

    The Company's progress has continued to accelerate in 2013.  It differentiates NW Bio as a leader in immune therapies for cancer in multiple ways, including the following:

  • having 3 distinct product lines, with 2 products at the Phase III stage, and the 3rd product in the process of entering an unusually broad combined Phase I/II trial;
  • having 2 products that are each expected to be applicable to all solid tumor cancers (one for cases with tumors that are surgically removed and the other for inoperable tumors);
  • having manufacturing processes for 2 products that have been accepted by regulators for clinical trials at the Phase III level (which processes must be the same as will be used for commercialization) – a significant milestone, especially for cell therapy products;
  • having operations (both clinical and manufacturing) established in both the US and Europe, the 2 largest medical markets in the world;
  • having over 180 issued and pending patents worldwide;
  • having numerous chances to win in the near term, with 3 parallel product programs with ongoing value milestones;
  • having extensive external validations, through regulatory decisions from highly respected regulators in 3 countries (US, UK and Germany), and multiple large marquee partners. '/>"/>

  • SOURCE Northwest Biotherapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
    2. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
    3. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
    4. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
    5. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
    6. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
    7. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
    8. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
    9. Archimedes Inc. Renews Annual Marketing Agreement with HealthEconomics.Com
    10. Palatin Technologies To Present At The 25th Annual ROTH Conference
    11. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... About Bioactive Material Bioactive ... are increasingly becoming popular due to their ability ... having a negative impact on the human health. ... tissue repair materials in surgical procedures. Bioactive materials ... glass-ceramics, and composites. The major end-users of bioactive ...
    (Date:9/23/2014)... France (PRWEB) September 23, 2014 ... of laboratory personnel since 1968 and Burdinola, supplier of ... of a new filtered fume hood. , ... laboratory fume hood, Burdinola will now offer an innovative ... a wide range of chemicals, best-in-class detection technology, and ...
    (Date:9/23/2014)... ATCC, the premier global biological materials resource and ... to the senior leadership team. Barbie Bigelow has joined ... and Dr. Maryellen de Mars also joins as the ... are new positions at ATCC. , ... described the additions as part of a revitalization strategy ...
    (Date:9/23/2014)... September 23, 2014 Follow ... gaining steady popularity the world over, due to ... Growth in the marketplace is expected to come ... in developing countries. Several sub-Saharan countries in the ... have already implemented genetically engineered crop production strategies. ...
    Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
    ... MILWAUKEE Catalyst International, a global provider of ... suite of platform-independent SCE applications. , ,"We're expanding ... customers' increasing demand for integrated fulfillment solutions from ... boundaries," said Jim Treleaven, President and CEO of ...
    ... WAUKESHA, WI. - RedPrairie Corporation , has ... electronic product code (EPC)-compliant radio frequency identification ... in a real-world environment. The RFID Lab is ... tag placement and readability as they prepare for ...
    ... supports plans for growth and strategic investments , ... and services company, today announced it has signed a ... Merchants and Manufacturers BanCorp (MMBC) , a Milwaukee-based ... credit, from which no monies have been drawn, was ...
    Cached Biology Technology:RedPrairie Builds RFID Lab - Enables Real-World Testing 2
    (Date:9/22/2014)... University researchers are studying a potential new treatment that ... in which scars develop in the lungs and severely ... miR-29, which is delivered to lung tissue intravenously. In ... reversed fibrosis after several days. , The findings ... Molecular Medicine . , "The mimic, when injected into ...
    (Date:9/22/2014)... Rochelle, NY, September 22, 2014Cassava, also known as tapioca, ... yields in areas of Africa, Asia, and Latin America ... the availability of novel enzymes and processes designed to ... be used to produce sweeteners such as glucose, fructose, ... to corn, as described in a Review article in ...
    (Date:9/22/2014)... Antarctic fishes that manufacture their own "antifreeze" ... also suffer an unfortunate side effect, researchers report: ... bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences . ... undesirable consequence of the evolution of antifreeze proteins ...
    Breaking Biology News(10 mins):Reversing the effects of pulmonary fibrosis 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3
    ... HOLLYWOOD, Calif., Aug. 20, 2012 (Pinksheets: MDBX) ( www.medboxinc.com ... 2nd quarter 2012 financials, which showed earnings of over $820,000 ... has almost doubled since the beginning of the year, and ... Medbox earns all its revenue through consulting services and the ...
    ... Southampton and the National Oceanography Centre, Southampton has found ... increase the bleaching susceptibility of reef corals. Corals ... a layer of living tissue covering the calcareous skeletons. ... within the coral polyps. The coral animal ...
    ... effort at Arizona State University to educate and train ... by the National Science Foundation (NSF). Through its Integrative ... is providing $3 million to ASU to help develop ... with the skills needed to find solutions to the ...
    Cached Biology News:Medbox, Inc. Releases 2nd Quarter Financials 2Improving water quality can help save coral reefs 2ASU awarded $3 million to research solar energy technologies, launch energy Ph.D. program 2
    ... a partial recombinant IFNA2. Immunogen: ... is produced in E. coli. The biological ... OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
    Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
    Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
    Mouse monoclonal antibody raised against a full length recombinant YARS. NCBI Entrez Gene ID = YARS...
    Biology Products: